Related Experiment Video
Updated: May 19, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Information-based sequential selection of clinical tests in risk assessment
Naama Parush1, Tal El-Hay, Michal Ozery-Flato
1IBM Research Haifa Labs, Haifa, Israel. naamap@il.ibm.com
This study introduces a new framework for clinical risk assessment, optimizing test decisions using information theory to reduce unnecessary examinations. The approach effectively minimizes blood tests without compromising predictive accuracy for conditions like type 2 diabetes.
Area of Science:
- Clinical decision support systems
- Health informatics
- Predictive modeling
Background:
- Sequential clinical risk assessment involves multiple tests over time.
- Decisions on further examinations are often based on expected value, which can be complex.
- Optimizing test selection is crucial to balance diagnostic accuracy with patient burden and cost.
Purpose of the Study:
- To develop a novel framework for optimizing decisions in sequential clinical risk assessment.
- To quantify the expected contribution of each test to risk assessment using information theory.
- To demonstrate the framework's utility in reducing unnecessary clinical examinations.
Main Methods:
- A decision-support framework was developed based on information theory principles.
- The expected contribution of each test was quantified conditional on previous test results.
- The framework was applied to a case study of type 2 diabetes onset prediction.
Main Results:
- The proposed framework effectively quantifies the value of additional tests in risk assessment.
- In the type 2 diabetes case study, a significant reduction in blood tests was achieved.
- Reducing the number of tests did not diminish the predictive model's accuracy.
Conclusions:
- The developed framework provides a robust method for optimizing sequential clinical examinations.
- Information-theoretic quantification supports informed decisions, preventing unnecessary tests.
- This approach enhances efficiency and reduces costs and patient discomfort in clinical risk assessment.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Automated Microbial Diagnostics
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Clinical Trials
There are four phases in a clinical trial. A phase one...
Statistical Software for Data Analysis and Clinical Trials

